Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 3, 2003, Pages

  Nakanishi, Shohei ^a   Yano, Shozo ^a   Nomura, Rikako ^a   Tsukamoto, Tatsuo ^a   Shimizu, Yasushi ^b   Shin, Jeongsoo ^b   Fukagawa, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Motomachi HD Clinic   (Japan)

Author keywords

Direct calcitriol injection therapy; Ectopic parathyroid gland; Nerve palsy; Percutaneous ethanol injection therapy; Secondary hyperparathyroidism; Ultrasonography

Indexed keywords

22 OXACALCITRIOL; ALCOHOL; CALCITRIOL; PARATHYROID HORMONE;

ARTICLE; BLEEDING; CALCIFICATION; CLINICAL PROTOCOL; COLOR ULTRASOUND FLOWMETRY; DISEASE SEVERITY; DOSE CALCULATION; DRUG EFFICACY; ECHOGRAPHY; ECTOPIC TISSUE; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; NERVE PARALYSIS; ORGAN BLOOD FLOW; ORGAN SIZE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SURGICAL TECHNIQUE; UREMIA;

CALCITRIOL; CALCIUM CHANNEL AGONISTS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INJECTIONS, INTRALESIONAL; PARATHYROID GLANDS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UREMIA;

EID: 0038691682     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med 1995; 333: 166-174
2. Delmez Ja Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: a role for increased sensitivity to calcium. J Clin Invest 1989; 83: 1349-1355
3. 3H] 1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med 1987; 316: 1573-1577
4. 3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 1996; 50: 34-39
5. Yano S, Sugimoto T. Tsukamoto et al. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 2000; 58: 1980-1986
6. Felsenfeld AJ, Llach F. Parathyroid gland function in chronic renal failure. Kidney Int 1993; 43: 771-789
7. Delmez JA, Tindra C, Grooms P et al. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: a role for increased sensitivity to calcium. J Clin Invest 1989; 83: 1349-1355
8. Brown AJ, Zhong M, Finch J et al. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 1996; 270: F454-F460
9. Canaff L, Hendy GN. Human calcium-sensing receptor gene. J Biol Chem 2002; 277: 30 337-30 350
10. Slatopolsky E, Weerts C, Thielan J et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143
11. Kurokawa K, Akizawa T, Suzuki M et al. Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study. Nephrol Dial Transplant 1996; 11: 121-129
12. Akizawa T, Suzuki M, Akiba T et al. Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients. Am J Kidney Dis 2001; 38 [Suppl. 1]: S147-S151
13. Fukagawa M, Kitaoka M, Tominaga Y et al. Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients: the Japanese strategy. Nephrol Dial Transplant 1999; 14: 2574-2577
14. Giangrande A, Cantu P, Solbianti L et al. Ultrasonically guided fine-needle alchol injection as an adjunct to medical treatment in secondary hyperparathyroidism. Proc EDTA-ERA 1984; 21: 895-901
15. Kitaoka M, Fukagawa M, Fukuda N et al. Direct injections of calcitriol into enlarged parathyroid glands in chronic dialysis patients with severe parathyroid hyperfunction. Nephrology 1995; 1: 563-567
16. Kitaoka M, Fukagawa M, Ogata E et al. Reduction of functioning parathyroid cell mass ethanol injection in chronic dialysis patients. Kidney Int 1994; 46: 1110-1117
17. Kakuta T, Fukagawa M, Fujisaki T et al. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 1999; 33: 1091-1099
18. Pons F, Torregrosa JV, Visal-Sicart S et al. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperthyroidism. Eur J Nucl Med 1997; 24: 1494-1498
19. Giangrande A, Castiglioni A, Solbiati L et al. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992; 7: 412-421
20. Shiizaki K, Hatamura I, Narukawa N et al. Ultrasound-guided direct maxacalcitol injection into parathyroid glands in chronic dialysis patients with severe secondary hyperparathyroidism (2HPT) induction of apoptosis in hyperplastic parathyroid cell. J Am Soc Nephrol 2001; 12 [Suppl]: A4037